Table Of ContentPathophysiology of
Blood Disorders
Notice
Medicine is an ever-changing science. As new research and clinical experience broaden our knowledge, changes in
treatment and drug therapy are required. In their efforts to provide information that is complete and generally in accord
with the standards accepted at the time of publication, the authors and the publisher of this work have checked with
sources believed to be reliable. However, in view of the possibility of human error or changes in medical sciences, neither
the authors nor the publisher nor any other party who has been involved in the preparation or publication of this work
warrants that the information contained herein is in every respect accurate or complete, and they disclaim all
responsibility for any errors or omissions or for the results obtained from use of the information contained in this work.
Readers are encouraged to confirm the information contained herein with other sources. For example and in particular,
readers are advised to check the product information sheet included in the package of each drug they plan to administer
to be certain that the information contained in this work is accurate and that changes have not been made in the
recommended dosage or in the contraindications for administration. This recommendation is of particular importance
in connection with new or infrequently used drugs.
a LANGE medical book
Pathophysiology of
Blood Disorders
H. Franklin Bunn, MD
Professor of Medicine
Harvard Medical School
Hematology Division
Brigham and Women’s Hospital
Boston, Massachusetts
Jon C. Aster, MD, PhD
Professor, Department of Pathology
Harvard Medical School
Staff Pathologist,
Department of Pathology
Brigham and Women’s Hospital
Boston, Massachusetts
New York Chicago San Francisco Lisbon London Madrid Mexico City
Milan New Delhi San Juan Seoul Singapore Sydney Toronto
Copyright © 2011 by The McGraw-Hill Companies, Inc. All rights reserved. Except as permitted under the United States Copyright Act of
1976, no part of this publication may be reproduced or distributed in any form or by any means, or stored in a database or retrieval system,
without the prior written permission of the publisher.
ISBN: 978-0-07-171377-1
MHID: 0-07-171377-8
The material in this eBook also appears in the print version of this title: ISBN: 978-0-07-171378-8,
MHID: 0-07-171378-6.
All trademarks are trademarks of their respective owners. Rather than put a trademark symbol after every occurrence of a trademarked
name, we use names in an editorial fashion only, and to the benefit of the trademark owner, with no intention of infringement of the
trademark. Where such designations appear in this book, they have been printed with initial caps.
McGraw-Hill eBooks are available at special quantity discounts to use as premiums and sales promotions, or for use in corporate training
programs. To contact a representative please e-mail us at [email protected].
TERMS OF USE
This is a copyrighted work and The McGraw-Hill Companies, Inc. (“McGraw-Hill”) and its licensors reserve all rights in and to the work.
Use of this work is subject to these terms. Except as permitted under the Copyright Act of 1976 and the right to store and retrieve one
copy of the work, you may not decompile, disassemble, reverse engineer, reproduce, modify, create derivative works based upon, transmit,
distribute, disseminate, sell, publish or sublicense the work or any part of it without McGraw-Hill’s prior consent. You may use the
work for your own noncommercial and personal use; any other use of the work is strictly prohibited. Your right to use the work may be
terminated if you fail to comply with these terms.
THE WORK IS PROVIDED “AS IS.” McGRAW-HILL AND ITS LICENSORS MAKE NO GUARANTEES OR WARRANTIES AS
TO THE ACCURACY, ADEQUACY OR COMPLETENESS OF OR RESULTS TO BE OBTAINED FROM USING THE WORK,
INCLUDING ANY INFORMATION THAT CAN BE ACCESSED THROUGH THE WORK VIA HYPERLINK OR OTHERWISE,
AND EXPRESSLY DISCLAIM ANY WARRANTY, EXPRESS OR IMPLIED, INCLUDING BUT NOT LIMITED TO IMPLIED
WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. McGraw-Hill and its licensors do not
warrant or guarantee that the functions contained in the work will meet your requirements or that its operation will be uninterrupted or
error free. Neither McGraw-Hill nor its licensors shall be liable to you or anyone else for any inaccuracy, error or omission, regardless of
cause, in the work or for any damages resulting therefrom. McGraw-Hill has no responsibility for the content of any information accessed
through the work. Under no circumstances shall McGraw-Hill and/or its licensors be liable for any indirect, incidental, special, punitive,
consequential or similar damages that result from the use of or inability to use the work, even if any of them has been advised of the
possibility of such damages. This limitation of liability shall apply to any claim or cause whatsoever whether such claim or cause arises
in contract, tort or otherwise.
Contents
Contributors vii | Preface ix
1. Introduction to Blood and II
P A R T
Hematopoietic Tissues
Jon C. Aster 1 HEMOSTASIS AND THROMBOSIS 141
2. Hematopoiesis
13. Overview of Hemostasis
David Scadden and Jon C. Aster 14
H. Franklin Bunn and Bruce Furie 142
14. Platelet Disorders
I H. Franklin Bunn and Bruce Furie 157
PA R T
15. Inherited Coagulation Disorders
ANEMIA AND RED CELL
H. Franklin Bunn and Bruce Furie 170
DISORDERS 29
16. Acquired Coagulation Disorders
H. Franklin Bunn and Bruce Furie 179
3. Overview of the Anemias
H. Franklin Bunn 30 17. Thrombotic Disorders
4. Anemias Due to Bone Marrow Failure or H. Franklin Bunn and Kenneth A. Bauer 188
Infiltration
H. Franklin Bunn 42 P A R T III
5. Iron Homeostasis: Deficiency and Overload
WHITE BLOOD CELL
H. Franklin Bunn and Matthew M. Heeney 51
DISORDERS 199
6. Megaloblastic Anemias
H. Franklin Bunn and Matthew Heeney 63
18. Leukocyte Function and Non-malignant
7. Anemias Associated With Chronic Illness Leukocyte Disorders
H. Franklin Bunn 75 Jon C. Aster and Nancy Berliner 200
8. Thalassemia
19. Introduction to Hematologic Malignancies
H. Franklin Bunn and David G. Nathan 81
Jon C. Aster and Mark Fleming 216
9. Sickle Cell Disease
20. Myeloproliferative Disorders and Myelodysplastic
H. Franklin Bunn 95
Syndromes
10. Hemolytic Disorders of the Red Cell Membrane Jon C. Aster and Daniel J. DeAngelo 229
and Red Cell Metabolism
H. Franklin Bunn and Samuel E. Lux 110 21. Acute Leukemias
Jon C. Aster and Daniel J. Deangelo 244
11. Acquired Hemolytic Anemias
H. Franklin Bunn 122 22. Non-Hodgkin Lymphomas and Chronic
Lymphocytic Leukemias
12. Erythrocytosis
Jon C. Aster and Arnold Freedman 260
H. Franklin Bunn 133
v
vi Contents
23. Hodgkin Lymphoma P A R T IV
Jon C. Aster and Arnold Freedman 279
TRANSFUSION MEDICINE 301
24. Multiple Myeloma and
Related Disorders 25. Blood Transfusion
Jon C. Aster 287 H. Franklin Bunn and Richard Kaufman 302
26. Hematopoietic Stem Cell Transplantation
Jon C. Aster and Joseph H. Antin 314
Answers to Questions 325
Index 327
Contributors
Joseph H. Antin, M.D. Bruce Furie, M.D.
Professor of Medicine Professor of Medicine
Dana Farber Cancer Institute Beth Israel Deaconess Medical Center
Boston, Massachusetts Boston, Massachusetts
Kenneth A. Bauer, M.D. Richard M. Kaufman, M.D.
Professor of Medicine Assistant Professor of Pathology
Beth Israel Deaconess Medical Center Medical Director,
Boston, Massachusetts Adult Transfusion Service
Brigham & Women’s Hospital
Nancy Berliner, M.D.
Boston, Massachusetts
Professor of Medicine
Director of Hematology Matthew M Heeney, M.D.
Brigham and Women’s Hospital Assistant Professor of Pediatrics
Boston, Massachusetts Hematology/Oncology Fegan 704
Children’s Hospital Boston
Daniel J. DeAngelo, M.D., Ph.D.
Boston, Massachusetts
Associate Professor of Medicine
Dana Farber Cancer Institute Samuel E. Lux IV, M.D.
Boston, Massachusetts Professor of Pediatrics
Division of Hematology/Oncology
Mark D. Fleming, M.D., Ph.D.
Children’s Hospital Boston
Professor of Pathology
Boston, Massachusetts
Children’s Hospital Boston
Boston, Massachusetts David G. Nathan, M.D.
Professor of Pediatrics
Arnold S. Freedman, M.D.
Dana Farber Cancer Institute
Associate Professor of Medicine
Boston, Massachusetts
Department of Medical Oncology
Division of Hematologic Malignancies David T. Scadden, M.D.
Dana-Farber Cancer Institute Professor of Medicine
Boston, Massachusetts Center for Regenerative Medicine
Boston, Massachusetts
vii
This page intentionally left blank
CHAPTER 8 Th alassemia ix
Preface
Th e study of blood and hematologic disorders has in this course, and many of the fi gures have been taken
special appeal for medical students as well as phy- directly or adapted from their lectures. We wrote the
sicians at all stages of their training. Few specialties fi rst draft s of all the co-authored chapters and revised
have such a broad impact on other medical disci- them following in-depth input from our colleagues.
plines. A competent hematologist must be well- Moreover, each of us provided thorough reviews of
grounded in pathology, internal medicine, pediatrics, the others’ chapters. All fi gures in this book were
and surgery. Conversely, both generalists and other redrawn by a single artist and vetted by both of us.
specialists regularly encounter patients with anemia, We hope that these measures have enabled our book
hemorrhage, thrombosis, and hematologic malignan- to achieve uniformity of style and clarity along with a
cies. For many students, the close kinship of hematol- high level of scientifi c rigor and clinical relevance.
ogy with laboratory medicine is an added virtue. Few We are indebted to a number of individuals who
medical disciplines enjoy such a rich array of reliable helped bring our book to fruition. James Shanahan,
and informative diagnostic tests, and none has stron- Karen Edmonson, and Armen Ovsepyan at McGraw-
ger underpinnings in contemporary molecular and Hill provided critical editorial advice including guid-
cell biology and molecular pathology. ance on how to make the book useful and interesting to
Our book is designed to introduce medical stu- students. Jessica Hughes and Muriel Goutas provided
dents to the physiological principles underlying the invaluable secretarial help. Dr. Jeff Kutok (Brigham
regulation and function of blood cells and hemo- and Women’s Hospital) and Carola von Kapff con-
stasis as well as the pathophysiologic mechanisms tributed images of some of the peripheral smears
responsible for the development of blood disorders. used in the book. About 10 months prior to publica-
We have placed more emphasis on principles than tion, a draft of this book was provided to 180 Harvard
on practice. Accordingly, we have avoided technical medical students, class of 2012. Many were remarkably
details pertaining to diagnostic tests and procedures conscientious and astute in picking up technical as well
as well as the compilation of specifi c drugs and dos- as conceptual errors. We are grateful for their input,
ages. Instead, issues pertaining to diagnosis and man- which improved the fi nal version of the book substan-
agement are covered primarily within a framework of tially. Finally, we thank our wives, Erin Malone and
pathogenesis. Betsy Bunn for their love and support.
Th e organization and contents of the book are
H. Franklin Bunn
based on a 3-week hematology course given to stu-
Jon C. Aster
dents in their second year at Harvard Medical School.
August 2010
All of the authors of individual chapters are lecturers
ix
Description:A concise full-color review of the mechanisms of blood diseases and disorders – based on a Harvard Medical School hematology course2015 Doody's Core Title!4 STAR DOODY'S REVIEW!"This is a superb book. Deceptively small, yet packs a wallop. The emphasis on principles instead of practice is welcome.